Commentary: Return to intended radiation therapy-Criteria for resection?
作者信息
Dux Joseph, Grosser Rachel, Adusumilli Prasad S
机构信息
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY.
出版信息
J Thorac Cardiovasc Surg. 2019 Sep;158(3):930-931. doi: 10.1016/j.jtcvs.2019.04.050. Epub 2019 Apr 30.
Abstract
摘要
相似文献
1
Commentary: Return to intended radiation therapy-Criteria for resection?评论：回归预期放疗——切除标准？
J Thorac Cardiovasc Surg. 2019 Sep;158(3):930-931. doi: 10.1016/j.jtcvs.2019.04.050. Epub 2019 Apr 30.
2
Commentary: Adjuvant intensity-modulated radiation therapy for malignant pleural mesothelioma: Suspension of intention.评论：恶性胸膜间皮瘤的辅助调强放射治疗：意向中止。
J Thorac Cardiovasc Surg. 2019 Sep;158(3):932-933. doi: 10.1016/j.jtcvs.2019.03.023. Epub 2019 Mar 22.
3
Commentary: Biphasic malignant mesothelioma-Survival of the fittest.评论：双相性恶性间皮瘤——适者生存。
J Thorac Cardiovasc Surg. 2020 Apr;159(4):1596-1597. doi: 10.1016/j.jtcvs.2019.08.028. Epub 2019 Sep 9.
4
Commentary: Asbestos exposure and mesothelioma risk.评论：石棉暴露与间皮瘤风险。
Int J Epidemiol. 2018 Dec 1;47(6):1758-1759. doi: 10.1093/ije/dyy176.
5
Commentary: Surgeon versus mesothelioma in a thoracic cage match.评论：胸廓“比赛”中的外科医生与间皮瘤
J Thorac Cardiovasc Surg. 2020 Jun;159(6):2522-2523. doi: 10.1016/j.jtcvs.2020.01.057. Epub 2020 Feb 7.
6
Commentary: Is thoracic cage volume a new parameter for clinical staging in mesothelioma?评论：胸廓容积是间皮瘤临床分期的一个新参数吗？
J Thorac Cardiovasc Surg. 2020 Jun;159(6):2520-2521. doi: 10.1016/j.jtcvs.2019.12.048. Epub 2020 Jan 7.
7
Commentary: Mesothelioma: The Guinness world record holder in thromboembolism.评论：间皮瘤：血栓栓塞方面的吉尼斯世界纪录保持者。
J Thorac Cardiovasc Surg. 2020 Oct;160(4):1074-1075. doi: 10.1016/j.jtcvs.2019.12.082. Epub 2020 Jan 11.
8
Commentary: Past and current asbestos exposure and future mesothelioma risks in Britain.评论：英国过去和当前的石棉暴露情况以及未来患间皮瘤的风险
Int J Epidemiol. 2018 Dec 1;47(6):1756-1757. doi: 10.1093/ije/dyy175.
9
Commentary: Know your enemy-Understanding futility in the battle against malignant pleural mesothelioma.评论：了解你的敌人——理解在对抗恶性胸膜间皮瘤的战斗中的徒劳。
J Thorac Cardiovasc Surg. 2020 Jun;159(6):2523-2524. doi: 10.1016/j.jtcvs.2020.01.034. Epub 2020 Jan 31.
10
Ionizing radiation: a risk factor for mesothelioma.电离辐射：间皮瘤的危险因素。
Cancer Causes Control. 2009 Oct;20(8):1237-54. doi: 10.1007/s10552-009-9357-4. Epub 2009 May 15.
本文引用的文献
1
Return to intended oncologic treatment after surgery for malignant pleural mesothelioma.恶性胸膜间皮瘤手术后返回预期的肿瘤治疗。
J Thorac Cardiovasc Surg. 2019 Sep;158(3):924-929. doi: 10.1016/j.jtcvs.2019.02.129. Epub 2019 Apr 16.
2
Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis.恶性胸膜间皮瘤的癌症定向手术的长期生存结果：倾向评分匹配分析。
J Clin Oncol. 2017 Oct 10;35(29):3354-3362. doi: 10.1200/JCO.2017.73.8401. Epub 2017 Aug 17.
3
Induction chemotherapy, extrapleural pneumonectomy and adjuvant radiotherapy for malignant pleural mesothelioma.恶性胸膜间皮瘤的诱导化疗、胸膜外全肺切除术和辅助放疗。
Eur J Cardiothorac Surg. 2017 Nov 1;52(5):975-981. doi: 10.1093/ejcts/ezx122.
4
Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.现代保肺三联疗法治疗恶性胸膜间皮瘤患者的疗效改善
J Thorac Oncol. 2017 Jun;12(6):993-1000. doi: 10.1016/j.jtho.2017.02.026. Epub 2017 Mar 21.
5
Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma.半胸强度调制胸膜放射治疗（IMPRINT）作为恶性胸膜间皮瘤患者肺保留多模式治疗一部分的II期研究
J Clin Oncol. 2016 Aug 10;34(23):2761-8. doi: 10.1200/JCO.2016.67.2675. Epub 2016 Jun 20.
6
Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma.胸膜纤维板剥脱术与胸膜外全肺切除术治疗间皮瘤后生存情况的Meta分析
Ann Thorac Surg. 2015 Feb;99(2):472-80. doi: 10.1016/j.athoracsur.2014.09.056. Epub 2014 Dec 20.
7
Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis.恶性胸膜间皮瘤胸膜切除术/胸膜剥脱术后的半胸强度调制放射治疗：毒性、失败模式及配对生存分析
Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):149-56. doi: 10.1016/j.ijrobp.2014.08.343. Epub 2014 Oct 25.
8
Reliability of the American Society of Anesthesiologists physical status scale in clinical practice.美国麻醉医师协会身体状况量表在临床实践中的可靠性。
Br J Anaesth. 2014 Sep;113(3):424-32. doi: 10.1093/bja/aeu100. Epub 2014 Apr 11.
9
A feasibility study evaluating Surgery for Mesothelioma After Radiation Therapy: the "SMART" approach for resectable malignant pleural mesothelioma.评估放疗后行胸膜间皮瘤手术的可行性研究：可切除恶性胸膜间皮瘤的 SMART 方法。
J Thorac Oncol. 2014 Mar;9(3):397-402. doi: 10.1097/JTO.0000000000000078.
10
Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma.胸膜外全肺切除和半胸部强度调制放射治疗恶性胸膜间皮瘤后的失败模式、毒性和生存。
J Thorac Oncol. 2013 Feb;8(2):238-45. doi: 10.1097/JTO.0b013e31827740f0.
Zotero 插件